|
1
|
WCRF (2014) World Cancer Research Fund
International. http://www.wcrf.org/
|
|
2
|
Tomeo CA, Colditz GA, Willett WC,
Giovannucci E, Platz E, Rockhill B, Dart H and Hunter D: Harvard
report on cancer prevention. Volume 3: Prevention of colon cancer
in the United States. Cancer Causes Control. 10:167–180. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fearon ER: Molecular genetics of
colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saif MW and Chu E: Biology of colorectal
cancer. Cancer J. 16:196–201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Issa JP: Colon cancer: It's CIN or CIMP.
Clin Cancer Res. 14:5939–5940. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
UEG (2014) Colorectal cancer in Europe.
http://www.ueg.eu/press/crceurope/
|
|
7
|
Peipins LA and Sandler RS: Epidemiology of
colorectal adenomas. Epidemiol Rev. 16:273–297. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fearon ER and Vogelstein B: A genetic
model for colorectal tumorigenesis. Cell. 61:759–767. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vogelstein B and Kinzler KW: Cancer genes
and the pathways they control. Nat Med. 10:789–799. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wood LD, Parsons DW, Jones S, Lin J,
Sjöblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, et al: The
gnomic landscapes of human breast and colorectal cancers. Science.
318:1108–1113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bhalla A, Zulfiqar M, Weindel M and
Shidham VB: Molecular diagnostics in colorectal carcinoma. Clin Lab
Med. 33:835–859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chung SJ, Kim YS, Yang SY, Song JH, Kim D,
Park MJ, Kim SG, Song IS and Kim JS: Five-year risk for advanced
colorectal neoplasia after initial colonoscopy according to the
baseline risk stratification: A prospective study in 2452
asymptomatic Koreans. Gut. 60:1537–1543. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nusko G, Hahn EG and Mansmann U: Risk of
advanced metachronous colorectal adenoma during long-term
follow-up. Int J Colorectal Dis. 23:1065–1071. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Euler VUS and Gaddum JH: An unidentified
depressor substance in certain tissue extracts. J Physiol.
72:74–87. 1931. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ho WZ, Lai JP, Zhu XH, Uvaydova M and
Douglas SD: Human monocytes and macrophages express substance P and
neurokinin-1 receptor. J Immunol. 159:5654–5660. 1997.PubMed/NCBI
|
|
16
|
Rollandy I, Dreux C, Imhoff V and
Rossignol B: Importance of the presence of the N-terminal
tripeptide of substance P for the stimulation of
phosphatidylinositol metabolism in rat parotid gland: A possible
activation of phospholipases C and D. Neuropeptides. 13:175–185.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pradier L, Heuillet E, Hubert JP, Laville
M, Le Guern S and Doble A: Substance P-evoked calcium mobilization
and ionic current activation in the human astrocytoma cell line U
373 MG: Pharmacological characterization. J Neurochem.
61:1850–1858. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Luo W, Sharif TR and Sharif M: Substance
P-induced mitogenesis in human astrocytoma cells correlates with
activation of the mitogen-activated protein kinase signaling
pathway. Cancer Res. 56:4983–4991. 1996.PubMed/NCBI
|
|
19
|
DeFea KA, Zalevsky J, Thoma MS, Déry O,
Mullins RD and Bunnett NW: beta-arrestin-dependent endocytosis of
proteinase-activated receptor 2 is required for intracellular
targeting of activated ERK1/2. J Cell Biol. 148:1267–1281. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Muñoz M, Rosso M and Coveñas R: The NK-1
receptor: A new target in cancer therapy. Curr Drug Targets.
12:909–921. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Muñoz M, Rosso M, Robles-Frias MJ,
Salinas-Martín MV, Rosso R, González-Ortega A and Coveñas R: The
NK-1 receptor is expressed in human melanoma and is involved in the
antitumor action of the NK-1 receptor antagonist aprepitant on
melanoma cell lines. Lab Invest. 90:1259–1269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Esteban F, Gonzalez-Moles MA, Castro D,
Martin-Jaen Mdel M, Redondo M, Ruiz-Avila I and Muñoz M: Expression
of substance P and neurokinin-1-receptor in laryngeal cancer:
Linking chronic inflammation to cancer promotion and progression.
Histopathology. 54:258–260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rosso M, Robles-Frías MJ, Coveñas R,
Salinas-Martín MV and Muñoz M: The NK-1 receptor is expressed in
human primary gastric and colon adenocarcinomas and is involved in
the antitumor action of L-733,060 and the mitogenic action of
substance P on human gastrointestinal cancer cell lines. Tumour
Biol. 29:245–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hennig IM, Laissue JA, Horisberger U and
Reubi JC: Substance-P receptors in human primary neoplasms: Tumoral
and vascular localization. Int J Cancer. 61:786–792. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schulz S, Stumm R, Röcken C, Mawrin C and
Schulz S: Immunolocalization of full-length NK1 tachykinin
receptors in human tumors. J Histochem Cytochem. 54:1015–1020.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Muñoz M, Rosso M and Coveñas R: A new
frontier in the treatment of cancer: NK-1 receptor antagonists.
Curr Med Chem. 17:504–516. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kage R, Leeman SE and Boyd ND: Biochemical
characterization of two different forms of the substance P receptor
in rat submaxillary gland. J Neurochem. 60:347–351. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rosso M, Muñoz M and Berger M: The role of
neurokinin-1 receptor in the microenvironment of inflammation and
cancer. ScientificWorldJournal. 2012:3814342012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fong TM, Anderson SA, Yu H, Huang RR and
Strader CD: Differential activation of intracellular effector by
two isoforms of human neurokinin-1 receptor. Mol Pharmacol.
41:24–30. 1992.PubMed/NCBI
|
|
30
|
Patel HJ, Ramkissoon SH, Patel PS and
Rameshwar P: Transformation of breast cells by truncated
neurokinin-1 receptor is secondary to activation by
preprotachykinin-A peptides. Proc Natl Acad Sci USA.
102:17436–17441. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou Y, Zhao L, Xiong T, Chen X, Zhang Y,
Yu M, Yang J and Yao Z: Roles of full-length and truncated
neurokinin-1 receptors on tumor progression and distant metastasis
in human breast cancer. Breast Cancer Res Treat. 140:49–61. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pagedar NA, Wang W, Chen DH, Davis RR,
Lopez I, Wright CG and Alagramam KN: Gene expression analysis of
distinct populations of cells isolated from mouse and human inner
ear FFPE tissue using laser capture microdissection-a technical
report based on preliminary findings. Brain Res. 1091:289–299.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nonn L, Vaishnav A, Gallagher L and Gann
PH: mRNA and micro-RNA expression analysis in laser-capture
microdissected prostate biopsies: Valuable tool for risk assessment
and prevention trials. Exp Mol Pathol. 88:45–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yokota Y, Sasai Y, Tanaka K, Fujiwara T,
Tsuchida K, Shigemoto R, Kakizuka A, Ohkubo H and Nakanishi S:
Molecular characterization of a functional cDNA for rat substance P
receptor. J Biol Chem. 264:17649–17652. 1989.PubMed/NCBI
|
|
36
|
Masu Y, Nakayama K, Tamaki H, Harada Y,
Kuno M and Nakanishi S: cDNA cloning of bovine substance-K receptor
through oocyte expression system. Nature. 329:836–838. 1987.
View Article : Google Scholar
|
|
37
|
Baker SJ, Morris JL and Gibbins IL:
Cloning of a C-terminally truncated NK-1 receptor from guinea-pig
nervous system. Brain Res. 111:136–147. 2003. View Article : Google Scholar
|
|
38
|
Lai JP, Ho WZ, Kilpatrick LE, Wang X,
Tuluc F, Korchak HM and Douglas SD: Full-length and truncated
neurokinin-1 receptor expression and function during
monocyte/macrophage differentiation. Proc Natl Acad Sci USA.
103:7771–7776. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lai JP, Cnaan A, Zhao H and Douglas SD:
Detection of full-length and truncated neurokinin-1 receptor mRNA
expression in human brain regions. J Neurosci Methods. 168:127–133.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gillespie E, Leeman SE, Watts LA, Coukos
JA, O'Brien MJ, Cerda SR, Farraye FA, Stucchi AF and Becker JM:
Truncated neurokinin-1 receptor is increased in colonic epithelial
cells from patients with colitis-associated cancer. Proc Natl Acad
Sci USA. 108:17420–17425. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Krause JE, Chirgwin JM, Carter MS, Xu ZS
and Hershey AD: Three rat preprotachykinin mRNAs encode the
neuropeptides substance P and neurokinin A. Proc Natl Acad Sci USA.
84:881–885. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Shigemoto R, Yokota Y, Tsuchida K and
Nakanishi S: Cloning and expression of a rat neuromedin K receptor
cDNA. J Biol Chem. 265:623–628. 1990.PubMed/NCBI
|
|
43
|
Bowden JJ, Garland AM, Baluk P, Lefevre P,
Grady EF, Vigna SR, Bunnett NW and McDonald DM: Direct observation
of substance P-induced internalization of neurokinin 1 (NK1)
receptors at sites of inflammation. Proc Natl Acad Sci USA.
91:8964–8968. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bradesi S, Svensson CI, Steinauer J,
Pothoulakis C, Yaksh TL and Mayer EA: Role of spinal microglia in
visceral hyperalgesia and NK1R up-regulation in a rat model of
chronic stress. Gastroenterology. 136(1339–1348): e1–e2. 2009.
|
|
45
|
Steinhoff MS, von Mentzer B, Geppetti P,
Pothoulakis C and Bunnett NW: Tachykinins and their receptors:
Contributions to physiological control and the mechanisms of
disease. Physiol Rev. 94:265–301. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Meshki J, Douglas SD, Lai JP, Schwartz L,
Kilpatrick LE and Tuluc F: Neurokinin 1 receptor mediates membrane
blebbing in HEK293 cells through a Rho/Rho-associated coiled-coil
kinase-dependent mechanism. J Biol Chem. 284:9280–9289. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Koon HW, Zhao D, Na X, Moyer MP and
Pothoulakis C: Metalloproteinases and transforming growth
factor-alpha mediate substance P-induced mitogen-activated protein
kinase activation and proliferation in human colonocytes. J Biol
Chem. 279:45519–45527. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Castagliuolo I, Valenick L, Liu J and
Pothoulakis C: Epidermal growth factor receptor transactivation
mediates substance P-induced mitogenic responses in U-373 MG cells.
J Biol Chem. 275:26545–26550. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Castagliuolo I, Morteau O, Keates AC,
Valenick L, Wang CC, Zacks J, Lu B, Gerard NP and Pothoulakis C:
Protective effects of neurokinin-1 receptor during colitis in mice:
Role of the epidermal growth factor receptor. Br J Pharmacol.
136:271–279. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Barak LS, Warabi K, Feng X, Caron MG and
Kwatra MM: Real-time visualization of the cellular redistribution
of G protein-coupled receptor kinase 2 and beta-arrestin 2 during
homologous desensitization of the substance P receptor. J Biol
Chem. 274:7565–7569. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jorgensen R, Holliday ND, Hansen JL, Vrecl
M, Heding A, Schwartz TW and Elling CE: Characterization of
G-protein coupled receptor kinase interaction with the neurokinin-1
receptor using bioluminescence resonance energy transfer. Mol
Pharmacol. 73:349–358. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kwatra MM, Schwinn DA, Schreurs J, Blank
JL, Kim CM, Benovic JL, Krause JE, Caron MG and Lefkowitz RJ: The
substance P receptor, which couples to Gq/11, is a substrate of
beta-adrenergic receptor kinase 1 and 2. J Biol Chem.
268:9161–9164. 1993.PubMed/NCBI
|
|
53
|
Li H, Leeman SE, Slack BE, Hauser G,
Saltsman WS, Krause JE, Blusztajn JK and Boyd ND: A substance P
(neurokinin-1) receptor mutant carboxyl-terminally truncated to
resemblea naturally occurring receptor isoform displays enhanced
responsiveness and resistance to desensitization. Proc Natl Acad
Sci USA. 94:9475–9480. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Rosso M, Robles-Frias MJ, Coveñas R,
Salinas-Martin MV and Muñoz M: The NK-1 receptor is expressed in
human primary gastric and colon adenocarcinomas and is involved in
the antitumor action of L-733,060 and the mitogenic action of
substance P on human gastrointestinal cancer cell lines. Tumour
Biol. 29:245–254. 2008. View Article : Google Scholar : PubMed/NCBI
|
